Hydrogen sulfide is formed in the human intestinal tract as the end product of the anaerobic microbial degradation of sulfur compounds present in mucus, bile or proteins. Since human gut microbial sulfur metabolism has been poorly characterized, we aimed to identify and isolate the microorganisms involved in sulfide formation. Fresh fecal samples from one healthy donor and one diagnosed with irritable bowel syndrome were used as inocula for enrichments that were supplemented with sulfate or sulfite as electron acceptors in combination with different electron donors. After two transfers, cultures with high sulfide production were selected and the phylogenetic composition of the enriched microbial communities was determined. Sulfite respiration and cysteine degradation were the dominant sulfidogenic processes, and the most abundant bacteria enriched belonged to Bilophila and Clostridium cluster XIVa. Different isolates were obtained and remarkably included a novel sulfite reducer, designated strain 2C. Strain 2C belongs to the Veillonellaceae family of Firmicutes phylum and showed limited (91%) 16S rRNA gene sequence similarity with that of known Sporomusa species and hence may represent a novel genus. This study indicates that bacteria that utilize sulfite and organic sulfur compounds rather than merely sulfate are relevant for human intestinal sulfur metabolism.
INTRODUCTION
The human gastrointestinal (GI) tract is colonized by billions of commensal microbes, which constitute a complex and diverse community known as the gut microbiota (Qin et al. 2010; Flint et al. 2012) . The luminal hydrolysis of undigested carbohydrates into monosugars and fermentation to short-chain fatty acids has been extensively studied, whereas the intestinal microbial sulfur metabolism has received less attention (den Besten et al. 2013) .
Sulfur is the third most abundant trace element in humans by percent of mass (Parcell 2002) . Humans require intake of organic sulfur sources such as methionine, cysteine/cystine and taurine, present in meat, eggs and dairy products (Magee et al. 2000) . Organic sulfur compounds can be used by mammalian cells as building blocks for tissues, or to form secreta such as mucin and bile acids (Wu 2009 ). Inorganic sulfur, such as sulfate and sulfite, which mainly derives from food preservation, cannot be used by the mammalian cells for energy conservation (Florin et al. 1993; Gibson Macfarlane and Cummings 1993) . On the other hand, in the GI tract, both organic and inorganic sulfur compounds are sources for microbiota to grow and are used, either assimilatory to synthesize cysteine or methionine or dissimilatory and fermentatively to release sulfide. To date, the sulfide levels in the human intestine are not measured, but in human feces a range of 0.3 to 3.4 mmol L −1 was detected (Magee et al. 2000) . Although low concentrations of sulfide (37-462.5 μmol L −1 ) may act as neuromodulator (Schicho et al. 2006; Krueger et al. 2010) , higher concentrations of sulfide can cause DNA damage of epithelium cells (Attene-Ramos et al. 2007 ) and impair metabolic functions such as butyrate oxidation in colonic epithelial cells (Hamer et al. 2008) . Consequently, it has been suggested that sulfide could be involved in intestinal disorders such as inflammatory bowel disease and irritable bowel syndrome (IBS) (Nakamura et al. 2010; Medani et al. 2011) . However, such a link between sulfur biotransformation and diseases has not yet been convincingly shown (Ijssennagger, van der Meer and van Mil 2016) and needs to be investigated. Sulfate reduction in the human GI tract has primarily been studied related to sulfide toxicity. Sulfate-reducing bacteria (SRB) in the GI tract of animals and humans have been detected (Hilton and Oleszkiewicz 1988; Qin et al. 2010) . The genus Desulfovibrio is generally the most abundant (Scanlan, Shanahan and Marchesi 2009) , while Desulfobacter, Desulfobulbus and Desulfotomaculum were also present (Nava et al. 2011) . In vitro incubation studies of Levine et al. (1998) using human feces suggested that sulfate was a less efficient source for sulfide production than organic sulfur-containing compounds. Unfortunately, this study did not include a microbial characterization to reveal the involved microbes. Hence, the aim of our research was to determine the microbial communities involved in the degradation of sulfur compounds leading to sulfide formation and to isolate novel microbial players.
MATERIAL AND METHODS

Samples, media and cultivation
To increase the diversity of the inocula source, fresh fecal samples from one healthy subject and one suffering from IBS were collected and inoculated separately. The study was approved by CCMO Netherlands (project ID: NL2907008109). One milliliter of an 1% (w/v) diluted fecal sample from each donor was inoculated into a 120 mL serum bottle containing 50 mL of O 2 -free basal medium as described by Stams et al. (1993) . The enrichments were supplemented with 0.1 g L Both sets of enrichments with healthy donor (HEA) and IBSdiagnosed donor fecal samples were first incubated for 14 days (primary incubation). On day 15, cultures with higher sulfide production than the control group were selected and 1 mL of culture was transferred to a fresh medium to perform a secondary incubation for another 9 days under the same condition. Sulfide (1 mM) and cysteine (4 mM) were used as reducing agents for both primary and secondary enrichment in HEA enrichments. Since a background sulfide production was observed from the cysteine, titanium citrate was used as reducing agent for IBS enrichments.
Analytical methods
Sulfide was fixed immediately by adding 50 μL of 5% (w/v) ZnCl 2 to 1 mL of each sample and measured by methylene-blue method (Cline 1969) . Samples were also fixed with 5% (v/v) of methanol to stabilize sulfite (Michigami and Ueda 1994) . Sulfate and sulfite were analyzed using a Dionex 1000 ion chromatograph unit (Dionex, Sunnyvale, CA) equipped with an IonPac AS17 Anion-Exchange column operating with a 0.1 mL min −1 flow rate at 30
• C. Organic compounds were quantified by highperformance liquid chromatograph with a Varian Metacarb 67H 300 mm column and sulfuric acid (0.01 N) eluent at a flow rate of 0.8 mL min −1 . Gases such as methane and H 2 were measured using a gas chromatograph (Shimadzu, Kyoto, Japan) as described by Florentino et al. (2015) .
Bacterial community analysis
An aliquot (1-5 mL) of well-homogenized liquid culture was concentrated by centrifuging at 13 400 g for 10 min, and DNA was extracted from the pellet by FastDNA SPIN Kit for Soil (MP Biomedicals, Solon, OH) according to the manufacturer's instructions. PCR was performed and purified in the same procedure of Timmers et al. (2015) for both bacterial and archaeal 16S rRNA genes. The purified PCR products were then cloned into Escherichia coli XL1-Blue Competent Cells (Agilent Technologies, Santa Clara, CA) by using the pGEM Easy Vector Systems (Promega, Madison, WI). All steps mentioned above were done following the manufacturers' instructions. Sanger sequencing was performed by GATC Biotech (Konstanz, Germany) using SP6 (5 -ATTTAGGTGACACTATAGAA-3 ) as sequencing primer. The sequences were trimmed with DNA Baser software (version 4.20.0. Heracle BioSoft SRL, Pitesti, Romania) to remove vector contamination and manually checked. Later they were aligned with the multiple sequence aligner SINA (Pruesse, Peplies and Glöckner 2012) and merged with the Silva SSU Ref database (release 111). Phylogenetic trees were constructed in the ARB software package (v. 6) by the same algorithm (Ludwig et al. 2004 ) described previously (Timmers et al. 2015) . Sequences were deposited in ENA under the accession numbers LT623288 to LT623571.
Genomic and metagenomic datamining
Blast search (Gish and States 1993) of the enzymes of the sulfite reduction pathway of Desulfovibrio desulfuricans strain ATCC 27774 (NC 011883) was performed against the genome of Bilophila wadsworthia strain 3 1 6 (NZ KE150238). For metagenomic datamining, 50 assembled and reviewed metagenome datasets of human stool microbial communities were selected from IMG/MER of JGI database (see Table S3 , Supporting Information). 'Dissimilatory sulfite reductase', 'cysteine desulfhydrase' and 'taurine dehydrogenase' were used as query for the search. Scaffolds containing the target genes were selected and their phylogeny was analyzed by IMG/MER database.
Isolation and sulfur metabolism of the isolates
Enrichments were selected for further isolation when they showed highly enriched (abundance >50%) of novel strains (16S rRNA gene sequence similarity <98.7%), according to Stackebrandt (2006) . Isolation strategies combined pasteurization in liquid media at 80
• C for 15 min, repeated serial dilution, antibiotic treatments and streaking on agar plates. After pure cultures were obtained, cloning and phylogenetic reconstruction were conducted as described in the bacterial community analysis section in addition of extra sequencing of the 16S rRNA gene with T7 primer (5 -TAATACGACTCACTATAGGG-3 ). Sequences amplified with both SP6 and T7 primers were then trimmed, combined and deposited in ENA under the accession numbers LT623572 and LT623573. Both strains 2C and YI were tested with API R 50 CH, (bioMérieux SA, Lyon, France) according to the manufacturer's instructions. Using the same O 2 -free basal medium supplied with trace elements, vitamins solution and a final concentration of 0.5% yeast extract, the isolates were tested in different relevant substrates. Sulfate (20 mM), sulfite (5 mM) and taurine (10 mM) were tested separately as an electron acceptor in combination of 20 mM of either butyrate, pyruvate, lactate or Lcysteine (10 mM). Negative control of both electron donor and acceptor was included as well. Compounds consumption and production were monitored in the same way as described in the analytical methods section.
RESULTS AND DISCUSSION
Enrichment experiments
Methane and H 2 were never detected, neither in the primary nor in the secondary enrichments. None of the enrichments showed sulfide production coupled to sulfate reduction either (Tables S1  and S2 , Supporting Information). In both HEA and IBS enrichments provided with sulfite, higher sulfide production was detected after the first transfer when H 2 , lactate or pyruvate served as electron donor (Fig. 1A and C) . In the absence of any electron acceptor, higher sulfide production was observed when cysteine was added as a substrate in both HEA and IBS enrichments (Fig. 1B and D) . When using ox-bile as substrate, higher sulfide production occurred in the HEA enrichment, in the presence of sulfite, whereas for IBS enrichment, maximum production of sulfide was observed in the enrichment without sulfite (Fig. 1A  and D) . Hence, for both HEA and IBS enrichments, sulfite reduction and cysteine utilization were the dominant sulfidogenic processes. These results are in line with those from Levine et al. (1998) who pointed out that sulfate was a less efficient source for sulfide production than cysteine, taurocholate and mucin when incubating human fecal samples in vitro.
Phylogenetic analysis of selected enrichments based on 16S rRNA gene clone libraries
Bilophila was the most commonly enriched genus in all selected cultures for both HEA and IBS enrichments (Fig. 2, see Figs S1 and S2, Supporting Information, for rarefaction curves) except for those with cysteine as sole substrate. It was especially abundant in the enrichment with H 2 and sulfite of the HEA enrichment (up to 90% of the sequences). The closest cultured relative to the obtained sequences is Bilophila wadsworthia (average 16S rRNA gene identity 99%; Fig. S3 , Supporting Information), which is the only cultured species within the genus (da Silva et al. 2008) . Bilophila wadsworthia is a commensal human GI tract microbiota, which is phylogenetically related to Desulfovibrio desulfuricans with a 91.4% 16S rRNA gene similarity. Bilophila wadsworthia is not able to reduce sulfate, instead it can conserve energy by performing dissimilatory sulfite reduction; it can use taurine as a source of sulfite (Laue et al. 2001) . The enzymes involved in sulfite reduction were found in the genome of B. wadsworthia (Fig. 3) : DsrA, DsrB, DsrC and the membrane complex involved in electron transport (complex DsrMKJOP) from the membrane to the DsrC trisulfide (Leavitt et al. 2016) . The growth rate of B. wadsworthia was higher with H 2 /taurine than with lactate/taurine and pyruvate/taurine (da Silva et al. 2008) . This may explain that in our experiment under H 2 /sulfite condition for both HEA and IBS enrichments, the abundance of Bilophila was largely promoted. When bile served as the only substrate, Bilophila spp. were also highly enriched in IBS enrichment, representing 84% of the sequences (Fig. 2) . This is explained by the ability of B. wadsworthia to ferment taurine leading to sulfide production (da Silva et al. 2008) . Under this condition, Escherichia/Shigella represented 10% of the cloned sequences. The related species was Escherichia coli (∼99% average 16S rRNA gene identity, Fig. S3 ). The antimicrobial activity of bile can select or exclude certain microbes in the human GI ecosystem (Ridlon et al. 2014) . Several intestinal pathogens are bile resistant and therefore highly favored when bile is present (Ananieva et al. 2002) .
There has been a shift from traditional diet habits-high in vegetables and low meat content-to modern diet habits more based on processed foods, high in protein and saturated fats (Jew, AbuMweis and Jones 2009) . After taking a high-fat diet, bile formation is promoted since bile improves the digestion of fat (Lefebvre et al. 2009 ). Devkota et al. (2012) correlated consumption of a high saturated fat with increased taurocholic acid, which promoted B. wadsworthia abundance and colitis in a mouse model. Hence, the role of bile and B. wadsworthia in the sulfur cycle in the human GI tract needs to receive more attention.
Clostridium cluster XIVa was the second most abundant group enriched, and was especially abundant (51% of the total sequences) in the HEA enrichment where cysteine was utilized as substrate (Fig. 2) . The enriched Clostridium species from this culture were mainly related with three species: Clostridium aldenense (∼97% average 16S rRNA gene identity), C. citroniae (∼98% average identity) and C. bolteae (98% identity) (Fig. S3) . All three species were isolated from human clinical samples and were detected in human fecal samples as well (Warren et al. 2006; Pequegnat et al. 2013) . Taking up a substantial part (10%-40%) of the total human GI tract bacteria, Clostridium spp. have important roles in the maintenance of overall gut function and were suggested to be leading players in the maintenance of gut homeostasis (Lopetuso et al. 2013 ).
Isolation and characterization
The different isolation strategies applied led to the isolation of two novel isolates: strain YI (97% 16S rRNA gene similarity to 
indicates that the tested bacteria could ferment the substrate, '−' indicates not.
Eubacterium limosum) and strain 2C (91% 16S rRNA gene similarity to that of representatives of the Sporomusa cluster and Anaeroarcus cluster) (Fig. 4) . The carbohydrate utilization patterns of both strains are listed in Table 1 . Strain 2C utilizes a broader range of substrates for fermentation than strain YI. Moreover, strain YI did not form sulfide from sulfate or sulfite. Remarkably, strain 2C shows sulfite reduction with pyruvate resulting in acetate and sulfide production (Fig. 5, Equations 1  and 3 ). Pyruvate also supports fermentative growth with acetate accumulation (Equations 1 and 4). Sulfate was not reduced when tested with butyrate, pyruvate or lactate. Strain 2C ferments cysteine to sulfide and acetate (Equations 1, 3 and 4). Besides, it can also ferment taurine while releasing thiosulfate and acetate. Taurine fermentation was described for Desulforhopalus singaporensis and Desulfonispora thiosulfatigenes leading to either sulfide or to thiosulfate (Denger, Stackebrandt and Cook 1999;  Figure 5. Growth of strain 2C on pyruvate and sulfite to yield sulfide and acetate. On all data series, a standard deviation is displayed over triplicate experiments. Lie et al. 1999) . Desulforhopalus singaporensis is a sulfate/sulfitereducing bacterium while D. thiosulfatigenes cannot reduce sulfate nor sulfite. These two species were isolated from marsh and fresh water. Strain 2C is the second human GI tract isolate that can ferment taurine and also perform sulfite reduction after B. wadsworthia (Laue, Denger and Cook 1997 
Datamining
Datamining of the available metagenomic datasets can give us a guidance of the unrevealed sulfidogenic potential in the human gut system. Our search for dissimilatory sulfite reductase in the selected metagenomes showed hits in Desulfovibrio, Bilophila, Eubacterium, Ruminococcus, Clostridium, Citrobacter and Escherichia (Table S4 , Supporting Information). The reversibility of this pathway for sulfide oxidation must be considered before drawing conclusions but surely it implies an active sulfur cycle in the human gut system. The search for taurine dehydrogenase gave no hit. Cysteine desulfhydrase is the key enzyme of bacterial cysteine fermentation, which releases sulfide, pyruvate and ammonia as products and is reported to be present in Clostridium spp. (Carbonero et al. 2012 ). In the current datamining search, D-cysteine desulfhydrase was present in C. citroniae, C. hathewayi, unclassified Clostridiales, E. coli, Oscillibacter spp. and B. wadsworthia in the selected database (Table S5 , Supporting Information).
CONCLUSION
The current in vitro work showed that sulfite and organic sulfurcontaining compounds, such as taurine, bile and cysteine, are potentially important sources of sulfide production. Sulfitereducing bacteria belonging to Bilophila and cysteine-fermenting bacteria belonging to Clostridium cluster XIVa were highly predominant in the enrichments. Furthermore, we isolated two strains, from which strain 2C represents a novel genus, and it is able to produce sulfide by cysteine fermentation as well as by sulfite reduction. In this work, sulfate did not promote growth of sulfate-reducing bacteria, suggesting that more attention should be given to sulfite reduction and anaerobic conversions of organic sulfur compounds to expand our knowledge of sulfide formation in the human GI tract.
